Occurrence of Tako-Tsubo Cardiomyopathy in Association with Ingestion of Serotonin/Noradrenaline Reuptake Inhibitors

Heart Lung and Circulation

Volumn 21, Issue 4, 2012, Pages 203-205

  Neil, Christopher J A ^a   Chong, Cher Rin ^a   Nguyen, Thanh H ^a   Horowitz, John D ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Antidepressants; Catecholamines; Stress cardiomyopathy; Tako Tsubo cardiomyopathy; Venlafaxine

Indexed keywords

DESVENLAFAXINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG OVERDOSE; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; LOW DRUG DOSE; MALE; POSTMENOPAUSE; PRIORITY JOURNAL; QT PROLONGATION; RISK ASSESSMENT; RISK FACTOR; TAKOTSUBO CARDIOMYOPATHY; TORSADE DES POINTES;

ADULT; AGED; AGED, 80 AND OVER; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NORMETANEPHRINE; OVERDOSE; PEPTIDE FRAGMENTS; SEROTONIN UPTAKE INHIBITORS; TAKOTSUBO CARDIOMYOPATHY;

EID: 84858277674     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.12.004     Document Type: Article

References (26)

1. Dib C., Asirvatham S., Elesber A., Rihal C., Friedman P., Prasad A. Clinical correlates and prognostic significance of electrocardiographic abnormalities in apical ballooning syndrome (Takotsubo/stress-induced cardiomyopathy). Am Heart J 2009, 157(May (5)):933-938.
2. Parodi G., Del Pace S., Carrabba N., Salvadori C., Memisha G., Simonetti I., et al. Incidence, clinical findings, and outcome of women with left ventricular apical ballooning syndrome. Am J Cardiol 2007, 99(January (2)):182-185.
3. Sato H.T., Taiteishi H., Uchida T. Takotsubo-type cardiomyopathy due to multivessel spasm. Clinical aspect of myocardial injury from ischemia to heart failure 1990, 56-64. Kagakuhyouronsha, Tokyo. K. Kodama, K. Haze, M. Hon (Eds.).
4. Bybee K.A., Kara T., Prasad A., Lerman A., Barsness G.W., Wright R.S., et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004, 141:858-865.
5. Gianni M., Dentali F., Grandi A.M., Sumner G., Hiralal R., Lonn E. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006, 27(July (13)):1523-1529.
6. Nef H.M., Mollmann H., Akashi Y.J., Hamm C.W. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 2010, 7(April (4)):187-193.
7. Sharkey S.W., Windenburg D.C., Lesser J.R., Maron M.S., Hauser R.G., Lesser J.N., et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010, 55(January (4)):333-341.
8. Wittstein I.S., Thiemann D.R., Lima J.A., Baughman K.L., Schulman S.P., Gerstenblith G., et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med 2005, 352(February (6)):539-548.
9. Cacciotti L., Camastra G.S., Beni S., Giannantoni P., Musaro S., Proietti I., et al. A new variant of Tako-tsubo cardiomyopathy: transient mid-ventricular ballooning. J Cardiovasc Med (Hagerstown) 2007, 8(December (12)):1052-1054.
10. Copetti R., Gonano C., Colombo T., Cattarossi L. "Inverted Takotsubo" pattern. Resuscitation 2007, 74(August (2)):394.
11. Samuelov-Kinori L., Kinori M., Kogan Y., Swartzon M., Shalev H., Guy D., et al. Takotsubo cardiomyopathy and QT interval prolongation: who are the patients at risk for torsades de pointes?. J Electrocardiol 2009, 42(July-August (4)):353-357. e1.
12. Elesber A.A., Prasad A., Lennon R.J., Wright R.S., Lerman A., Rihal C.S. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol 2007, 50(July (5)):448-452.
13. Vincent S., Bieck P.R., Garland E.M., Loghin C., Bymaster F.P., Black B.K., et al. Clinical assessment of norepinephrine transporter blockade through biochemical and pharmacological profiles. Circulation 2004, 109:3202-3207.
14. Bergman B.R., Reynolds H.R., Skolnick A.H., Castillo D. A case of apical ballooning cardiomyopathy associated with duloxetine. Ann Intern Med 2008, 149(August (3)):218-219.
15. Christoph M., Ebner B., Stolte D., Ibrahim K., Kolschmann S., Strasser R.H., et al. Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin-norepinephrine reuptake inhibitor Venlafaxine. Eur Neuropsychopharmacol 2010, 20(August (8)):594-597.
16. Daly M.J., Harbinson M.T., Dixon L.J., Spence M.S. An unusual case of mid-ventricular Takotsubo cardiomyopathy. QJM 2010, 103:695-696.
17. Nguyen T.H., Sverdlov N.C., Mahadavan A.L., Chirkov G., Kucia Y.Y., Stansborough A.M., et al. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy. Am J Cardiol 2011, 108(9):1316-1321.
18. Denney S.D., Lakkireddy D.R., Khan I.A. Long QT syndrome and torsade de pointes in transient left ventricular apical ballooning syndrome. Int J Cardiol 2005, 100(3):499-501.
19. Abraham J., Mudd J.O., Kapur N.K., Klein K., Champion H.C., Wittstein I.S. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol 2009, 53(April (15)):1320-1325.
20. Agarwal V.K.G., Hans N., Messerli F.H. Takotsubo-like cardiomyopathy in pheochromocytoma. Int J Cardiol 2011.
21. Fangio P., De Jonghe B., Appere-De-Vecchi C., Lacherade J.C., Terville J.P., Outin H., et al. Acute heart failure associated with venlafaxine poisoning. Am J Emerg Med 2007, 25(February (2)):210-211.
22. Rotondi F., Manganelli F., Carbone G., Stanco G. "Tako-tsubo" cardiomyopathy and duloxetine use. South Med J 2011, 104(May (5)):345-347.
23. Godkar D., Stensby J., Sinnapunayagam S., Niranjan S. Venlafaxine induced acute myocardial infarction with normal coronary arteries. Am J Ther 2009, 16(July-August (4)):365-366.
24. Stevens D.L. Duloxetine-associated tachycardia. Ann Pharmacother 2008, 42(October (10)):1511-1513.
25. Colucci V.J., Berry B.D. Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy. Ann Pharmacother 2008, 42(June (6)):882-887.
26. Hojer J., Hulting J., Salmonson H. Fatal cardiotoxicity induced by venlafaxine overdosage. Clin Toxicol (Phila) 2008, 46(April (4)):336-337.